Sharvani R, Dayanand D K, Shenoy Poornima, Sarmah Pooja
Assistant Professor, Department of Microbiology, Sapthagiri Institute of Medical Science and Research Centre , Bangalore, Karnataka, India .
Professor, Department of Microbiology, Sapthagiri Institute of Medical Science and Research Centre , Bangalore, Karnataka, India .
J Clin Diagn Res. 2016 May;10(5):DC06-8. doi: 10.7860/JCDR/2016/18102.7753. Epub 2016 May 1.
Enteric fever is a major problem especially in developing countries. Timely and appropriate treatment plays a very important role in reducing the mortality. Fluoroquinolones and cephalosporins are the treatment options for enteric fever. Recent studies have shown that it is time to reconsider the use of earlier antibiotics.
The study was aimed to know whether salvage is possible and to avoid treatment failures following fluoroquinolone usage.
A one year retrospective data of Salmonella species isolated from 319 blood samples from our hospital and other diagnostic centers were studied. Demographic data, organism isolated and their changing pattern of antibiogram were analysed.
Out of 319 Salmonella isolates, 52.4% (167) was Salmonella typhi (S. typhi) and 47.6% (152) Salmonella paratyphi A (S. paratyphi A), with a male preponderance. Most of the salmonellae were isolated in the months of June and July, with the majority being in the 1-10 and 21-30 years age groups. Both species were highly susceptible to chloramphenicol (95.2% and 100%) followed by third generation cephalosporins (97% and 98%), cotrimoxazole (95.8% and 98.6%) and ampicillin (94.6% and 93.4%) respectively. Highest resistance was seen for nalidixic acid (90.4% and100%) among both S. typhi and S. paratyphi A isolates followed by ciprofloxacin (62.2% and 54.6%) respectively. MDR to first line drugs was observed in a small proportion of S. typhi (1.7%) only.
The frequency of isolation of S. typhi and S. paratyphi A are in equal proportion and enteric fever is more prevalent in younger age group. It is ideal to adopt bivalent vaccination in Universal immunization schedule. The isolates show sensitivity to first line drugs, paving the way for salvage of the earlier drugs. Cephalosporins still remain the treatment of choice in MDR salmonella isolates.
伤寒是一个主要问题,尤其是在发展中国家。及时且恰当的治疗在降低死亡率方面起着非常重要的作用。氟喹诺酮类和头孢菌素类是治疗伤寒的选择。最近的研究表明,是时候重新考虑使用早期抗生素了。
本研究旨在了解是否有可能挽救病情,并避免在使用氟喹诺酮类药物后出现治疗失败的情况。
对从我院及其他诊断中心的319份血样中分离出的沙门氏菌属进行了为期一年的回顾性数据研究。分析了人口统计学数据、分离出的病原体及其抗菌谱的变化模式。
在319株沙门氏菌分离株中,52.4%(167株)为伤寒沙门氏菌(S. typhi),47.6%(152株)为甲型副伤寒沙门氏菌(S. paratyphi A),男性居多。大多数沙门氏菌在6月和7月分离得到,大多数患者年龄在1 - 10岁和21 - 30岁组。两种菌对氯霉素均高度敏感(分别为95.2%和100%),其次是第三代头孢菌素(分别为97%和98%)、复方新诺明(分别为95.8%和98.6%)以及氨苄西林(分别为94.6%和93.4%)。在伤寒沙门氏菌和甲型副伤寒沙门氏菌分离株中,对萘啶酸的耐药率最高(分别为90.4%和100%),其次是环丙沙星(分别为62.2%和54.6%)。仅在一小部分伤寒沙门氏菌(1.7%)中观察到对一线药物的多重耐药。
伤寒沙门氏菌和甲型副伤寒沙门氏菌的分离频率相当,伤寒在年轻人群中更为普遍。在通用免疫规划中采用二价疫苗是理想的。分离株对一线药物敏感,为挽救早期药物铺平了道路。头孢菌素类仍然是多重耐药沙门氏菌分离株的首选治疗药物。